Biocryst Pharmaceuticals (BCRX) Net Margin: 2010-2015
Historic Net Margin for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -129.87%.
- Biocryst Pharmaceuticals' Net Margin rose 26584.00% to -129.87% in Q3 2015 from the same period last year, while for Sep 2015 it was -93.64%, marking a year-over-year increase of 12956.00%. This contributed to the annual value of -372.40% for FY2014, which is 16813.00% down from last year.
- As of Q3 2015, Biocryst Pharmaceuticals' Net Margin stood at -129.87%, which was down 781.17% from 19.07% recorded in Q2 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Net Margin peaked at 972.33% during Q2 2012, and registered a low of -1,618.27% during Q2 2013.
- In the last 3 years, Biocryst Pharmaceuticals' Net Margin had a median value of -249.02% in 2014 and averaged -397.41%.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Net Margin soared by 118,732bps in 2012 and then plummeted by 259,060bps in 2013.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Net Margin stood at -231.97% in 2011, then soared by 118,732bps to 972.33% in 2012, then crashed by 259,060bps to -71.50% in 2013, then plummeted by 23,014bps to -301.63% in 2014, then surged by 26,584bps to -129.87% in 2015.
- Its last three reported values are -129.87% in Q3 2015, 19.07% for Q2 2015, and -228.95% during Q1 2015.